Karyotypic abnormalities in benign adrenocortical tumors producing aldosterone

Cancer Genet Cytogenet. 1993 Jul 1;68(1):78-81. doi: 10.1016/0165-4608(93)90078-z.

Abstract

Because familial hyperaldosteronism type II (FH-II) includes tumor formation, we examined the karyotypes of benign adrenocortical aldosterone-producing adenomas (APAs), including those from patients with FH-II. Cell culture was successful in 12 of 14 tumors removed, two of which were from patients with FH-II. Five of the 12 tumors cultured (one from a patient with FH-II) had abnormal karyotypes. All were from male patients, and loss of the Y chromosome was observed in each. One showed loss of chromosome 19, and another showed an unbalanced t(6;7) producing partial trisomy 7q. Oncogenes are present at these breakpoints, and loss of the Y chromosome and monosomy 19 have previously been reported in neoplasia. This is the first report of cytogenetic abnormalities in benign adrenocortical tumors.

MeSH terms

  • Adrenal Gland Neoplasms / genetics*
  • Adrenal Gland Neoplasms / metabolism
  • Adult
  • Aldosterone / metabolism*
  • Chromosome Aberrations*
  • Chromosome Deletion
  • Chromosome Disorders*
  • Female
  • Humans
  • Hyperaldosteronism / genetics*
  • Karyotyping
  • Male
  • Middle Aged
  • Trisomy
  • Tumor Cells, Cultured
  • Y Chromosome

Substances

  • Aldosterone